The post Actors, Creators Launch Coalition to Push AI Rules Amid Ongoing Legal Battles appeared on BitcoinEthereumNews.com. In brief The Creators Coalition on AIThe post Actors, Creators Launch Coalition to Push AI Rules Amid Ongoing Legal Battles appeared on BitcoinEthereumNews.com. In brief The Creators Coalition on AI

Actors, Creators Launch Coalition to Push AI Rules Amid Ongoing Legal Battles

For feedback or concerns regarding this content, please contact us at [email protected]

In brief

  • The Creators Coalition on AI said it aimed to set standards for the responsible use of generative AI.
  • The launch followed years of strikes, lawsuits, and labor disputes over AI.
  • Actor and co-founder Joseph Gordon-Levitt said the group planned to apply public pressure and pursue policy and legal action if needed.

A coalition of writers, actors, and technologists launched a new industry group on Tuesday to push for enforceable rules governing how artificial intelligence is trained and used across the entertainment industry.

The move follows disputes over AI that have escalated into strikes, lawsuits, and policy battles across Hollywood and the digital media economy.

The Creators Coalition on AI positions itself as a cross-industry effort, distinct from labor unions or collective bargaining, focusing on establishing voluntary standards that can influence broader industry practices and policies.

Co-founder and actor Joseph Gordon-Levitt said the group was sparked by filmmaker Daniel Kwan, one-half of the directing duo behind Everything Everywhere All at Once.

In a video posted on X, Gordon-Levitt said the group was responding to how some companies have rushed to deploy AI and strike deals without clear rules for creators.

“We’re all facing the same threat, not from generative AI as a technology, but from the unethical business practices many big AI companies are guilty of,” Gordon-Levitt said. “I’ve said this before: I think the tech itself is exciting and inspiring. It could mean a lot for the future of art and creativity, but that won’t happen by itself if we take the path of least resistance.”

Gordon-Levitt said the coalition was designed to extend beyond the traditional entertainment industry.

“This is not just artists,” he said. “It’s all the highly skilled people who work around them, and it’s not just Hollywood. It includes YouTubers, podcasters, newsletter writers, really all creators.”

The group’s launch follows years of critics warning that AI tools could be used to replicate scripts, voices, and performances without consent or compensation.

Those issues became central during the SAG-AFTRA and Writers Guild of America strikes in 2023 and have since fueled lawsuits over copyright, training data, and likeness rights.

Since the strikes, several US states have enacted laws regulating AI, but those efforts now face challenges from the Trump Administration, which seeks to create a national standard.

Other founding members of the Creators Coalition on AI include actress and director Natasha Lyonne, filmmaker David Goyer, Center for Humane Technology co-founder Randima Fernando, and Berggruen Institute president Dawn Nakagawa.

Gordon-Levitt said the group was built on the idea that creators could use public pressure, collective action, and, if necessary, litigation and legislation to assert their influence.

“Creators actually have a lot of power if we come together,” he said.

More than 500 people signed the coalition’s letter, including Natalie Portman, Cate Blanchett, Ben Affleck, Guillermo del Toro, Aaron Sorkin, Ava DuVernay, and Taika Waititi, followed by members of the Directors Guild of America, SAG-AFTRA, the Writers Guild of America, the Producers Guild of America, and IATSE, alongside independent artists, executives, and technologists.

“We built this for the long haul, but we’re here, and we’re in the game,” Gordon-Levitt said. “That’s the important thing for today.”

Generally Intelligent Newsletter

A weekly AI journey narrated by Gen, a generative AI model.

Source: https://decrypt.co/352634/creators-launch-coalition-to-push-ai-rules-amid-ongoing-legal-battles

Market Opportunity
EPNS Logo
EPNS Price(PUSH)
$0.012057
$0.012057$0.012057
+1.39%
USD
EPNS (PUSH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09